Chlorhexidine-alcohol
PreclinicalSmall molecule
Chlorhexidine-alcohol is one of 4 small molecule programs targeting Skin. It is currently in Preclinical.
1
Indications
4
Total Trials
0
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
9 competitors in Skin
#DrugCompanyPhaseTrials
1Dupixent
AAzienda U.S.L. 1 di Massa e Carrara
Phase 1
Litifilimab
BiogenPhase 1
Na-ASP-2 Hookworm Vaccine
AAlbert B. Sabin Vaccine Institute
Preclinical
Chlorhexidine-alcohol
WWashington University School of Medicine
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Postoperative Infections1 trial
Efficacy Study of Antiseptic Preoperative Scrubs in Prevention of Postoperative Infections
Completed·—·Phase 3·NCT00290290·849 enrolled
Povidone Iodine1 trial
Chlorhexidine1 trial
Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline
Completed·—·Phase 2/3·NCT03640507·30 enrolled
Skin1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Chlorhexidine-alcohol. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details